• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老对预处理保护大鼠心脏免受缺血-再灌注损伤能力的影响。

Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.

作者信息

Schulman D, Latchman D S, Yellon D M

机构信息

Hatter Institute for Cardiovascular Studies, University College London Hospital and Medical School, WC1E 6DB, United Kingdom.

出版信息

Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1630-6. doi: 10.1152/ajpheart.2001.281.4.H1630.

DOI:10.1152/ajpheart.2001.281.4.H1630
PMID:11557553
Abstract

Ischemic preconditioning (IP) reduces infarct size in young animals; however, its impact on aging is underinvestigated. The effect of variations in IP stimuli was studied in young, middle-aged, and aged rat hearts. Isolated hearts underwent 35 min of regional ischemia and 120 min of reperfusion. Hearts with IP were subjected to either one ischemia-reperfusion cycle (5 min of ischemia and 5 min of reperfusion per cycle) or three successive cycles before 35 min of regional ischemia. Additional studies investigated the effects of pharmacological preconditioning in aged hearts using the adenosine A(1) receptor agonist 2-chloro-N(6)-cyclopentyladenosine, the protein kinase C analog 1,2-dioctanoyl-sn-glycerol, and the mitochondrial ATP-sensitive potassium (K(ATP))-channel opener diazoxide. Infarct sizes indicated that the aged rat heart could not be preconditioned via ischemic or pharmacological means. The middle-aged rat heart had a blunted IP response compared with the young adult (only an increased IP stimulus caused a significant reduction in infarct size). These results suggest that there are defects within the IP signaling cascade of the aged heart. Clinical relevance is important if we are to use any IP-like mimetics to the benefit of an aging population.

摘要

缺血预处理(IP)可减小幼龄动物的梗死面积;然而,其对衰老的影响研究不足。在幼龄、中年和老年大鼠心脏中研究了IP刺激变化的影响。离体心脏经历35分钟的局部缺血和120分钟的再灌注。接受IP处理的心脏在35分钟局部缺血前,经历一个缺血-再灌注循环(每个循环5分钟缺血和5分钟再灌注)或三个连续循环。额外的研究使用腺苷A(1)受体激动剂2-氯-N(6)-环戊基腺苷、蛋白激酶C类似物1,2-二辛酰基-sn-甘油和线粒体ATP敏感性钾(K(ATP))通道开放剂二氮嗪,研究了老年心脏中药理学预处理的效果。梗死面积表明老年大鼠心脏不能通过缺血或药理学手段进行预处理。与年轻成年大鼠相比,中年大鼠心脏的IP反应减弱(只有增加IP刺激才会导致梗死面积显著减小)。这些结果表明老年心脏的IP信号级联存在缺陷。如果我们要使用任何类似IP的模拟物来造福老年人群,临床相关性很重要。

相似文献

1
Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.衰老对预处理保护大鼠心脏免受缺血-再灌注损伤能力的影响。
Am J Physiol Heart Circ Physiol. 2001 Oct;281(4):H1630-6. doi: 10.1152/ajpheart.2001.281.4.H1630.
2
Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts.线粒体ATP敏感性钾通道的直接激活可模拟预处理,但蛋白激酶C激活在中年大鼠心脏中的效果较差。
Cardiovasc Res. 2001 Jan;49(1):56-68. doi: 10.1016/s0008-6363(00)00240-6.
3
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?抑制线粒体通透性转换孔开放:心肌预处理的新范例?
Cardiovasc Res. 2002 Aug 15;55(3):534-43. doi: 10.1016/s0008-6363(02)00455-8.
4
Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.长期暴露于R(-)-N6-(2-苯异丙基)腺苷后,缺血预处理对心肌的保护作用丧失与腺苷A1受体缺陷有关。
Mol Cell Biochem. 1998 Sep;186(1-2):19-25.
5
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.格列美脲,一种新型磺酰脲类药物,不会消除缺血预处理或二氮嗪所提供的心肌保护作用。
Circulation. 2001 Jun 26;103(25):3111-6. doi: 10.1161/01.cir.103.25.3111.
6
Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance.在患有胰岛素抵抗的Zucker肥胖大鼠中,针对缺血再灌注损伤的心肌预处理作用消失。
Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R920-6. doi: 10.1152/ajpregu.00520.2006. Epub 2006 Sep 28.
7
[The effects of diazoxide on myocardium function and the expressions of ERK and JNK in isolated spontaneous hypertension rat hearts].[二氮嗪对自发性高血压大鼠离体心脏心肌功能及细胞外信号调节激酶和应激活化蛋白激酶表达的影响]
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2006 Feb;22(1):50-3.
8
Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart.线粒体和肌膜ATP敏感性钾通道在犬心脏缺血预处理中的作用
Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H256-63. doi: 10.1152/ajpheart.2001.280.1.H256.
9
Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.诱导型一氧化氮合酶介导腺苷A(1)受体激活所诱导的延迟性心肌保护作用:来自基因敲除小鼠的证据。
Circulation. 2000 Aug 22;102(8):902-7. doi: 10.1161/01.cir.102.8.902.
10
Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants?通过开放线粒体三磷酸腺苷敏感性钾通道或抑制钠/氢交换进行缺血预处理:哪种是心脏移植的最佳保护策略?
J Thorac Cardiovasc Surg. 2001 Jan;121(1):155-62. doi: 10.1067/mtc.2001.111417.

引用本文的文献

1
Exercise-induced cardioprotection: From endogenous to exogenous mechanisms.运动诱导的心脏保护:从内源性机制到外源性机制。
Sports Med Health Sci. 2025 Mar 28;7(5):366-374. doi: 10.1016/j.smhs.2025.03.009. eCollection 2025 Sep.
2
Myocardial protection in cardiac surgery: a comprehensive review of current therapies and future cardioprotective strategies.心脏手术中的心肌保护:当前治疗方法与未来心脏保护策略的全面综述
Front Med (Lausanne). 2024 Jun 19;11:1424188. doi: 10.3389/fmed.2024.1424188. eCollection 2024.
3
Effects of transcutaneous electrical nerve stimulation on myocardial protection in patients undergoing aortic valve replacement: a randomized clinical trial.
经皮神经电刺激对主动脉瓣置换术患者心肌保护作用的随机临床试验。
BMC Anesthesiol. 2022 Mar 9;22(1):68. doi: 10.1186/s12871-022-01611-x.
4
Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms.促红细胞生成素在慢性肾脏病患者心血管保护中的作用:对其影响及机制的重新评估
Cardiovasc Drugs Ther. 2023 Dec;37(6):1175-1192. doi: 10.1007/s10557-022-07321-3. Epub 2022 Feb 12.
5
Effluent from ischemic preconditioned hearts confers cardioprotection independent of the number of preconditioning cycles.缺血预处理心脏的流出液可独立于预处理循环次数发挥心脏保护作用。
PLoS One. 2020 Dec 3;15(12):e0243220. doi: 10.1371/journal.pone.0243220. eCollection 2020.
6
Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury.缺血再灌注损伤过程中心肌细胞死亡的线粒体和线粒体非依赖性途径。
J Cell Mol Med. 2020 Apr;24(7):3795-3806. doi: 10.1111/jcmm.15127. Epub 2020 Mar 10.
7
Ageing, sex, and cardioprotection.衰老、性别与心脏保护
Br J Pharmacol. 2020 Dec;177(23):5270-5286. doi: 10.1111/bph.14951. Epub 2020 Feb 3.
8
Perioperative Cardioprotection by Remote Ischemic Conditioning.远程缺血预处理的围手术期心脏保护作用。
Int J Mol Sci. 2019 Sep 29;20(19):4839. doi: 10.3390/ijms20194839.
9
Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury.简讯:mTOR在衰老相关缺血/再灌注损伤中的意义
Aging Dis. 2019 Feb 1;10(1):116-133. doi: 10.14336/AD.2018.0501. eCollection 2019 Feb.
10
Conditioning-induced cardioprotection: Aging as a confounding factor.适应性诱导的心脏保护作用:衰老作为一个混杂因素
Korean J Physiol Pharmacol. 2018 Sep;22(5):467-479. doi: 10.4196/kjpp.2018.22.5.467. Epub 2018 Aug 27.